Focal Nodular Hyperplasia Clinical Trial
Official title:
"The Fingerprint: Spoke-wheel Sign" of Focal Nodular Hyperplasia: Assessment of Novel Ultrasound Approach Using Superb Microvascular Imaging Technique
NCT number | NCT02737865 |
Other study ID # | 2015-10-134-003 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2016 |
Est. completion date | April 25, 2019 |
Verified date | December 2019 |
Source | Samsung Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Focal nodular hyperplasia (FNH) in liver is the second common benign hepatic tumor. It
usually shows hypervascular mass on imaging studies and it is not easy to differentiate with
other hypervascular malignant tumor. For diagnosis of FNH, contrast-enhanced ultrasonography
(US) has been used to detect 'spoke-wheel sign', which can be typically seen in FNH. However,
temporal window of vascular phase using contrast-enhanced US (CEUS) is very short (about 10
sec) and coordination of patient`s respiration during US exam is absolutely needed. Thus, the
investigators will use Superb-Microvascular imaging (SMI, Toshiba, Japan) for detection of
'spoke-wheel sign' in patients with proven FNH, which enable to detect slow micro vascular
flow without using CEUS.
First, to compare the detection rate of 'spoke-wheel sign' between CEUS using sonazoid
(Perfluorobutane, GE healthcare) and SMI.
Second, to compare the accuracy of size measurement between gray-scale US and SMI (reference
standard: CEUS using sonazoid.)
Status | Completed |
Enrollment | 62 |
Est. completion date | April 25, 2019 |
Est. primary completion date | April 25, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Patients with biopsy or imaging proven focal nodular hyperplasia Exclusion Criteria: 1. Pregnant women 2. Patient`s age > 70 3. Egg allergy 4. Breast-feeding women |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Samsung Medical Center | Seoul |
Lead Sponsor | Collaborator |
---|---|
Samsung Medical Center |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Grading of spoke-wheel sign on CEUS using sonazoid and SMI in patients with focal nodular hyperplasia | a.To evaluate the detection rate of 'spoke-wheel sign' on CEUS using sonazoid and SMI (primary outcome). Each US findings during exam for patients with FNH were recorded by radiologist. The results were interpreted by consensus using 4 scale bar. 0. Absence of 'spoke-wheel sign' Mild suspicious of 'spoke-wheel sign' Highly suspicious of 'spoke-wheel sign' Definite "spoke-wheel sign' |
1 day | |
Secondary | Measurement error of focal nodular hyperplasia between b-mode US and SMI according to the reference standard, CEUS | To calculate the measurement error between b-mode US and SMI using measurement of maximum diameter of tumor. Reference standard is the size of tumor on sonazoid enhanced US. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02156700 -
Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors
|
N/A |